Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (Minibody) is designed to be expressed as the anti-CD20 scFv fused to N-terminus of Knob-CH3 domain and the anti-CD22 scFv to the Hole-CH3 domain, or vice versa. The CH3 domains are further stabilized by C-terminal disulfide bonds. This BsAb is designed for the research of Lymphoma; Leukemia; Antoimmune disease; Immune dysfunction disease therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY